| The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis PH Maxwell, MS Wiesener, GW Chang, SC Clifford, EC Vaux, ... Nature 399 (6733), 271-275, 1999 | 6312 | 1999 |
| Molecular subgroups of medulloblastoma: the current consensus MD Taylor, PA Northcott, A Korshunov, M Remke, YJ Cho, SC Clifford, ... Acta neuropathologica 123, 465-472, 2012 | 2144 | 2012 |
| Medulloblastoma comprises four distinct molecular variants PA Northcott, A Korshunov, H Witt, T Hielscher, CG Eberhart, S Mack, ... Journal of clinical oncology 29 (11), 1408-1414, 2011 | 1577 | 2011 |
| Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein ME Cockman, N Masson, DR Mole, P Jaakkola, GW Chang, SC Clifford, ... Journal of Biological Chemistry 275 (33), 25733-25741, 2000 | 1419 | 2000 |
| Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas M Kool, A Korshunov, M Remke, DTW Jones, M Schlanstein, PA Northcott, ... Acta neuropathologica 123, 473-484, 2012 | 1167 | 2012 |
| Subgroup-specific structural variation across 1,000 medulloblastoma genomes PA Northcott, DJH Shih, J Peacock, L Garzia, A Sorana Morrissy, ... Nature 488 (7409), 49-56, 2012 | 996 | 2012 |
| Dissecting the genomic complexity underlying medulloblastoma DTW Jones, N Jäger, M Kool, T Zichner, B Hutter, M Sultan, YJ Cho, ... Nature 488 (7409), 100-105, 2012 | 981 | 2012 |
| Subtypes of medulloblastoma have distinct developmental origins P Gibson, Y Tong, G Robinson, MC Thompson, DS Currle, C Eden, ... Nature 468 (7327), 1095-1099, 2010 | 959 | 2010 |
| Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features M Kool, J Koster, J Bunt, NE Hasselt, A Lakeman, P Van Sluis, D Troost, ... PloS one 3 (8), e3088, 2008 | 841 | 2008 |
| Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups DW Ellison, J Dalton, M Kocak, SL Nicholson, C Fraga, G Neale, ... Acta neuropathologica 121, 381-396, 2011 | 662 | 2011 |
| Risk stratification of childhood medulloblastoma in the molecular era: the current consensus V Ramaswamy, M Remke, E Bouffet, S Bailey, SC Clifford, F Doz, M Kool, ... Acta Neuropathologica, 2016 | 653 | 2016 |
| Medulloblastoma PA Northcott, GW Robinson, CP Kratz, DJ Mabbott, SL Pomeroy, ... Nature reviews Disease primers 5 (1), 11, 2019 | 575 | 2019 |
| β-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee DW Ellison, OE Onilude, JC Lindsey, ME Lusher, CL Weston, RE Taylor, ... Journal of Clinical Oncology 23 (31), 7951-7957, 2005 | 540 | 2005 |
| Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma N Zhukova, V Ramaswamy, M Remke, E Pfaff, DJH Shih, DC Martin, ... Journal of Clinical Oncology 31 (23), 2927-2935, 2013 | 538 | 2013 |
| Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study EC Schwalbe, JC Lindsey, S Nakjang, S Crosier, AJ Smith, D Hicks, ... The Lancet Oncology 18 (7), 958-971, 2017 | 529 | 2017 |
| Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease SC Clifford, ME Cockman, AC Smallwood, DR Mole, ER Woodward, ... Human molecular genetics 10 (10), 1029-1038, 2001 | 464 | 2001 |
| Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial B Lannering, S Rutkowski, F Doz, B Pizer, G Gustafsson, A Navajas, ... Journal of clinical oncology 30 (26), 3187-3193, 2012 | 386 | 2012 |
| Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables DW Ellison, M Kocak, J Dalton, H Megahed, ME Lusher, SL Ryan, W Zhao, ... Journal of clinical oncology 29 (11), 1400-1407, 2011 | 371 | 2011 |
| Cytogenetic prognostication within medulloblastoma subgroups DJH Shih, PA Northcott, M Remke, A Korshunov, V Ramaswamy, M Kool, ... Journal of clinical oncology 32 (9), 886-896, 2014 | 370 | 2014 |
| Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis UK Tyne Cell Cycle 5 (22), 2666-2670, 2006 | 358 | 2006 |
